Efficacy News and Research

RSS

Researchers develop new compound that inhibits growth of melanoma cells

An international team of researchers has developed a novel compound that successfully inhibits growth of melanoma cells by targeting specific epigenetic modifying proteins in these cells.

4 Jan 2018

Experts look for ways to end dietary deficiencies in essential micronutrients

One of the most ambitious programmes to provide lasting improvements in nutrition in sub-Saharan Africa begins today when a diverse multinational team of experts from agriculture to ethics start looking for ways to end dietary deficiencies in essential micronutrients.

3 Jan 2018

Study reveals new insights into role of self-help in inpatient psychotherapy

A randomized controlled trial published in the current issue of Psychotherapy and Psychosomatics discloses new insights into the role of self-help in inpatient psychotherapy. Depression is one of the most frequent and costly mental disorders.

3 Jan 2018

Migraine surgery leads to significant improvements in everyday functioning and coping ability

In addition to reducing headache frequency and severity, surgical treatment for migraine leads to significant improvements in everyday functioning and coping ability, according to a study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

3 Jan 2018

Diabetes drug holds promise of being developed into new treatment for Alzheimer's

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action.

2 Jan 2018

Researchers propose different approach to beat antibiotic-resistant superbugs

Got a sore throat? The doctor may write a quick prescription for penicillin or amoxicillin, and with the stroke of a pen help diminish public health and your own future health by helping bacteria evolve resistance to antibiotics.

30 Dec 2017

Gene therapy with CAR T-cells could create long-term immunity from HIV

Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells.

29 Dec 2017

Nanobiotix receives FDA approval for first immuno-oncology trial

NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).

26 Dec 2017

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.

26 Dec 2017

Nanomedicine platform can guide doctors to remove tumors and kill malignant cells

Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.

21 Dec 2017

FDA approves new gene therapy targeting rare form of inherited vision loss

The U.S. Food and Drug Administration today approved Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult patients with an inherited form of vision loss that may result in blindness.

19 Dec 2017

Study finds combination therapy as effective strategy to treat ovarian cancers

Researchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian cancer, with another small molecule inhibitor was effective to treat ovarian cancers without BRCA1 and BRCA2 gene mutations.

19 Dec 2017

C-Path receives FDA’s clinical outcome assessment qualification for SMDDS

Critical Path Institute's Patient-Reported Outcome Consortium announces its first clinical outcome assessment qualification from the US Food and Drug Administration for the Symptoms of Major Depressive Disorder Scale.

18 Dec 2017

Coloring books can have some positive effect, but not nearly as potent as art therapy

A new study shows that while those adult coloring books can reduce stress, they're still not art therapy.

15 Dec 2017

Researchers examine link between tumor mutational burden and response to immune checkpoint therapy

Predicting how patients will respond to anti-cancer therapies can be vital in informing clinical decisions and improving treatment outcome.

15 Dec 2017

Sugary-drink warning labels may help decrease obesity and overweight prevalence

Labels that warn people about the risks of drinking soda and other sugar-sweetened beverages can lower obesity and overweight prevalence suggests a new Johns Hopkins Bloomberg School of Public Health study.

14 Dec 2017

IPM begins first clinical trial of vaginal rings to prevent HIV in women

The nonprofit International Partnership for Microbicides announced today the start of the first clinical trial of vaginal rings designed to slowly release the antiretroviral drug dapivirine over three months to prevent HIV in women.

13 Dec 2017

Experts call for rigorous clinical trials in use of experimental fetal therapy

Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.

12 Dec 2017

Self-efficacy in exercise adoption appears to positively influence female veterans with FM symptoms

For female Veterans with fibromyalgia (FM) symptoms, the impact of believing in their ability to begin and sustain a long-term exercise program appears to positively influence their results.

12 Dec 2017

Retinal diseases could be treated by ophthalmic drops instead of intraocular injections

The Spanish firm Sylentis has developed a compound to treat diseases of the retina, such as age-related macular degeneration and diabetic retinopathy, which will be administered by ophthalmic drops instead of intraocular injections.

12 Dec 2017

Efficacy News and Research

Researchers develop new compound that inhibits growth of melanoma cells

Experts look for ways to end dietary deficiencies in essential micronutrients

Study reveals new insights into role of self-help in inpatient psychotherapy

Migraine surgery leads to significant improvements in everyday functioning and coping ability

Diabetes drug holds promise of being developed into new treatment for Alzheimer's

Researchers propose different approach to beat antibiotic-resistant superbugs

Gene therapy with CAR T-cells could create long-term immunity from HIV

Nanobiotix receives FDA approval for first immuno-oncology trial

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Nanomedicine platform can guide doctors to remove tumors and kill malignant cells

FDA approves new gene therapy targeting rare form of inherited vision loss

Study finds combination therapy as effective strategy to treat ovarian cancers

C-Path receives FDA’s clinical outcome assessment qualification for SMDDS

Coloring books can have some positive effect, but not nearly as potent as art therapy

Researchers examine link between tumor mutational burden and response to immune checkpoint therapy

Sugary-drink warning labels may help decrease obesity and overweight prevalence

IPM begins first clinical trial of vaginal rings to prevent HIV in women

Experts call for rigorous clinical trials in use of experimental fetal therapy

Self-efficacy in exercise adoption appears to positively influence female veterans with FM symptoms

Retinal diseases could be treated by ophthalmic drops instead of intraocular injections

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News